Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,330 | -15,198 | -15,080 | -9,764 | -15,825 |
| Depreciation Amortization | 1,608 | 1,698 | 887 | 1,023 | 809 |
| Accounts receivable | -1,967 | -1,208 | -67 | -1,624 | 1,754 |
| Accounts payable and accrued liabilities | -288 | -1,307 | -102 | 1,612 | -402 |
| Other Working Capital | -2,525 | -583 | -2,580 | -930 | 1,123 |
| Other Operating Activity | 4,656 | 4,544 | 2,254 | -1,473 | 3,786 |
| Operating Cash Flow | $-9,846 | $-12,054 | $-14,688 | $-11,156 | $-8,755 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -175 | -59 | N/A |
| Net Acquisitions | -37 | -157 | -5,000 | N/A | N/A |
| Investing Cash Flow | $-37 | $-157 | $-5,175 | $-59 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 3,078 |
| Debt Repayment | -1,250 | -313 | N/A | N/A | -2,790 |
| Common Stock Issued | 9,019 | 661 | N/A | 38,712 | 10,416 |
| Financing Cash Flow | $7,769 | $348 | $N/A | $38,712 | $10,704 |
| Exchange Rate Effect | -31 | -24 | -18 | 47 | 41 |
| Beginning Cash Position | 8,638 | 20,525 | 40,406 | 12,862 | 10,872 |
| End Cash Position | 6,493 | 8,638 | 20,525 | 40,406 | 12,862 |
| Net Cash Flow | $-2,145 | $-11,887 | $-19,881 | $27,544 | $1,990 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,846 | -12,054 | -14,688 | -11,156 | -8,755 |
| Capital Expenditure | N/A | N/A | -194 | -59 | N/A |
| Free Cash Flow | -9,846 | -12,054 | -14,882 | -11,215 | -8,755 |